Category: Psychedelics

Psyched Wellness Attracts Major Investment

Jeffrey Stevens, CEO & Director of Psyched Wellness (CSE: PSYC) joins us in today’s episode of the Daily Dive. Jeff sits down with us to discuss the evolution of the stigma towards mushrooms, and the interest in psychedelics. We then transition to a discussion on Psyched Wellness, where we hear about the process of development of CALM, the firms latest product, as well as the recent binding agreement with Gotham Green and My Crew Doses Inc.

Psyched Wellness is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The Company’s objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category.


Information for this briefing was found via Sedar and the companies mentioned. Canacom Group, the parent company of the Deep Dive, is currently long the equity of Psyched Wellness. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Numinus Wellness To Acquire MedBright AI In Bid To Add Artificial Intelligence To Portfolio

June 20, 2024, 09:41:47 AM

Red Light Holland To Consult PharmAla On Developing Medical Psilocybin

February 9, 2024, 08:50:24 AM

Filament Health Walks Away From SPAC Merger, US$14.4 Million Financing

December 20, 2023, 09:14:18 AM

Cybin Rallies After Steve Cohen’s Point 72 Disclosed 8.1% Equity Purchase

September 19, 2023, 03:42:00 PM

Filament Health To Merge With SPAC To Obtain Nasdaq Listing

July 19, 2023, 09:33:13 AM

Snowfall at the White House: Cocaine Found on White House Grounds Sparks Evacuation, Secret Service Investigation

July 4, 2023, 02:41:04 PM

FDA Releases Guidance for Psychedelic Drug Trials With Possibility of Removing Schedule I Classification

June 27, 2023, 03:03:00 PM

Psyched Wellness Attracts Major Investment

June 9, 2023, 01:30:00 PM

Quebec Makes History As First Province in Canada to Cover Psilocybin-Assisted Psychotherapy

December 21, 2022, 12:48:00 PM

Mind Medicine Prices $30 Million Offering At 30% Discount To Market

September 28, 2022, 09:28:04 AM

Bright Minds Begins Phase 1 Clinical Trials Focused On Treating Dravet Syndrome

August 31, 2022, 08:52:31 AM

Mindmed Completes 15-To-1 Reverse Split To Maintain Nasdaq Compliance

August 29, 2022, 08:21:39 AM
Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024